Found 454 matching trials
Effect of Dexamethasone as an Adjuvant to Bupivacaine in Bilateral Erector Spinae Block on Postoperative Pain and Diaphragmatic Function After Pediatric Cardiac Surgeries : A Randomized Controlled Clinical Trial NA The aim of this study is to figure out the efficacy of dexamethasone additi...
Show More Location
Multiple Locations
Learn More & Join Trial
Volume vs Concentration: Quadratus Lumborum Blocks With High Volume/Low Concentration or Low Volume/ High Concentration in Nephrectomies PHASE4 The quadratus lumborum has since 2016 become standard of care for abdominal...
Show More Location
UPMC shadyside hospital
Learn More & Join Trial
Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) PHASE3 Neutropenia, a condition characterized by an abnormally low number of infec...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone PHASE2 Recent prospective multicenter phase II study assessed the efficacy and tol...
Show More Location
Kosin University Gospel Hospital
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma PHASE2 This research study is evaluating a new drug called "nivolumab" as a possib...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma PHASE2 This phase II trial study assessing the activity of metformin when given to...
Show More Location
UOPECCAN - Hospital do Câncer de Cascavel
Learn More & Join Trial
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma PHASE2 Patients included in the study will receive induction treatment during 6 mo...
Show More Status
Active Not Recruiting
Location
Hospital Clínic de Barcelona
Learn More & Join Trial
The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia PHASE2 Randomized, open-label, multicenter study to compare the efficacy and safet...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
A Phase I/II Study of Intraperitoneal Paclitaxel in Patients With Metastatic Appendiceal Adenocarcinoma PHASE1 To find the recommended dose of the drug paclitaxel that can be given intra...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial